T1	PROC 46 111	Ensayo clínico fase I/II aleatorizado, exploratorio y prospectivo
T2	PROC 117 148	evaluar la seguridad y eficacia
T3	PROC 155 166	transfusión
#1	AnnotatorNotes T3	C1879316; Transfusion (procedure); Therapeutic or Preventive Procedure
T4	ANAT 206 219	tejido tímico
T5	PROC 226 248	prevención del rechazo
#2	AnnotatorNotes T5	C0547622; Prevention or Early Detection of Rejection of Transplant; Health Care Activity
T6	PROC 258 282	trasplantados de corazón
T7	ANAT 275 282	corazón
#3	AnnotatorNotes T7	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T8	PROC 306 325	Evaluar la eficacia
#4	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	PROC 332 354	prevención del rechazo
#5	AnnotatorNotes T9	C0547622; Prevention or Early Detection of Rejection of Transplant; Health Care Activity
T10	PROC 361 372	transfusión
#6	AnnotatorNotes T10	C1879316; Transfusion (procedure); Therapeutic or Preventive Procedure
T11	PROC 411 435	trasplantados de corazón
T12	ANAT 428 435	corazón
#7	AnnotatorNotes T12	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T13	PROC 568 589	trasplante de corazón
#8	AnnotatorNotes T13	C0018823; Heart Transplantation; Therapeutic or Preventive Procedure
T14	CHEM 631 656	fármacos inmunosupresores
#9	AnnotatorNotes T14	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T15	PROC 805 829	consentimiento informado
#10	AnnotatorNotes T15	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T16	DISO 874 894	Síndrome de DiGeorge
#11	AnnotatorNotes T16	C0012236; DiGeorge Syndrome; Disease or Syndrome
T17	ANAT 914 920	tímica
#12	AnnotatorNotes T17	C0040113; Thymus Gland; Body Part, Organ, or Organ Component
T18	PROC 939 952	Serología HIV
T19	DISO 966 990	Infección activa por EBV
#13	AnnotatorNotes T19	C0149678; Epstein-Barr Virus Infections; Disease or Syndrome
T20	PROC 1004 1020	hiperinmunizados
#14	AnnotatorNotes T20	C0596742; hyperimmunization; Therapeutic or Preventive Procedure
T21	CHEM 1025 1057	anticuerpos citotóxicos anti-HLA
T22	DISO 1087 1097	malignidad
#15	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process
T23	PROC 1149 1173	estudios de intervención
#16	AnnotatorNotes T23	C3274035; Interventional Study; Research Activity
T24	PROC 1224 1244	terapia de inducción
#17	AnnotatorNotes T24	C0600558; Neoadjuvant Therapy; Therapeutic or Preventive Procedure
T25	CHEM 1249 1260	Basiliximab
#18	AnnotatorNotes T25	C0676831; basiliximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T26	PROC 1306 1319	trasplantados
#19	AnnotatorNotes T26	C0040732; Transplantation; Therapeutic or Preventive Procedure
T27	PROC 1361 1375	diagnosticados
#20	AnnotatorNotes T27	C0011900; Diagnosis; Diagnostic Procedure
T28	DISO 1379 1400	enfermedad autoinmune
#21	AnnotatorNotes T28	C0004364; Autoimmune Diseases; Disease or Syndrome
T29	DISO 1408 1417	celiaquía
#22	AnnotatorNotes T29	C0007570; Celiac Disease; Disease or Syndrome
T30	DISO 1419 1444	hipotiroidismo autoinmune
#23	AnnotatorNotes T30	C0342158; Hypothyroidism, Autoimmune; Disease or Syndrome
T31	DISO 1446 1465	diabetes autoinmune
#24	AnnotatorNotes T31	C0205734; Diabetes, Autoimmune; Disease or Syndrome
T32	ANAT 170 182	células TREG
#25	AnnotatorNotes T32	C0039198; Regulatory T-Cell; Cell
T33	ANAT 376 391	células thyTreg
T34	ANAT 582 589	corazón
#26	AnnotatorNotes T34	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T35	CHEM 1263 1276	Timoglobulina
T36	Date 13 17	2018
T37	LIVB 252 257	niños
#27	AnnotatorNotes T37	C0008059; Child; Age Group
T39	LIVB 405 410	niños
#28	AnnotatorNotes T39	C0008059; Child; Age Group
T40	LIVB 466 474	Paciente
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Age 475 492	menor de dos años
T42	LIVB 594 603	Pacientes
#30	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T44	LIVB 665 671	padres
#31	AnnotatorNotes T44	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T46	LIVB 860 869	Pacientes
#32	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 949 952	HIV
#33	AnnotatorNotes T47	C0019682; HIV; Virus
T48	LIVB 987 990	EBV
#34	AnnotatorNotes T48	C0014644; Epstein-Barr virus; Virus
T49	LIVB 994 1003	Pacientes
#35	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 1061 1070	Pacientes
#36	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 1108 1117	Pacientes
#37	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Date 1177 1190	el último mes
T53	LIVB 1195 1204	Pacientes
#38	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1281 1290	Pacientes
#39	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 1336 1345	Pacientes
#40	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T38	LIVB 676 683	tutores
#41	AnnotatorNotes T38	C0871554; tutor; Professional or Occupational Group
T43	PHYS 724 734	comprender
#42	AnnotatorNotes T43	C0162340; Comprehension; Mental Process
T45	PHYS 906 920	función tímica
A1	Population_data T37 Age
A2	Population_data T39 Age
A3	Status T22 History_of
A4	Status T23 History_of
A5	Status T24 History_of
A6	Status T25 History_of
A7	Status T35 History_of
A8	Status T26 History_of
A9	Status T28 History_of
A10	Status T29 History_of
A11	Status T30 History_of
A12	Status T31 History_of
#43	AnnotatorNotes T1	C1515369; Therapeutic Exploratory Study; Research Activity + C1519043; Phase I/II Trial; Research Activity + C0034656; Randomization; Research Activity + C0033522; Prospective Studies; Research Activity
#44	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
#45	AnnotatorNotes T4	C1515430; Thymic Tissue; Tissue
#46	AnnotatorNotes T33	C0039198; Regulatory T-Cell; Cell + C1515430; Thymic Tissue; Tissue (?)
#47	AnnotatorNotes T11	C0018823; Heart Transplantation; Therapeutic or Preventive Procedure
#48	AnnotatorNotes T6	C0018823; Heart Transplantation; Therapeutic or Preventive Procedure
#49	AnnotatorNotes T35	C0730920; Thymoglobulin; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
T56	Neg_cue 604 607	sin
T57	CONC 608 624	contraindicación
A13	Assertion T57 Negated
#50	AnnotatorNotes T57	C0522473; Contraindication; Qualitative Concept
R1	Used_for Arg1:T32 Arg2:T3	
T58	Quantifier_or_Qualifier 183 192	autólogas
#51	AnnotatorNotes T58	C0439859; Autologous (qualifier value); Qualitative Concept
R2	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T58	
T59	Quantifier_or_Qualifier 193 219	obtenidas de tejido tímico
R3	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T59	
R4	Used_for Arg1:T3 Arg2:T5	
R5	Before Arg1:T5 Arg2:T6	
R6	Experiences Arg1:T37 Arg2:T3	
R7	Experiences Arg1:T37 Arg2:T5	
R8	Experiences Arg1:T37 Arg2:T6	
R9	Location_of Arg1:T7 Arg2:T6	
T60	Quantifier_or_Qualifier 392 401	autólogas
#52	AnnotatorNotes T60	C0439859; Autologous (qualifier value); Qualitative Concept
R10	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T60	
R11	Experiences Arg1:T39 Arg2:T11	
R12	Location_of Arg1:T12 Arg2:T11	
R13	Used_for Arg1:T33 Arg2:T10	
R14	Before Arg1:T9 Arg2:T11	
R15	Used_for Arg1:T10 Arg2:T9	
R16	Experiences Arg1:T39 Arg2:T9	
R17	Experiences Arg1:T39 Arg2:T10	
R18	Has_Age Arg1:T40 Arg2:T41	
T61	Observation 506 544	cumpla todos los requisitos necesarios
R19	Experiences Arg1:T40 Arg2:T61	
R20	Before Arg1:T61 Arg2:T13	
R21	Location_of Arg1:T34 Arg2:T13	
R22	Experiences Arg1:T42 Arg2:T14	
R23	Negation Arg1:T56 Arg2:T57	
T62	Observation 696 706	dispuestos
#53	AnnotatorNotes T62	C0600109; Willing; Finding (?)
R24	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T62	
R25	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T62	
T63	Observation 713 761	capaces de comprender el propósito y los riesgos
R27	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T63	
R28	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T63	
R30	Overlap Arg1:T62 Arg2:T15	
R31	Overlap Arg1:T63 Arg2:T15	
R32	Overlap Arg1:T43 Arg2:T15	
R33	Experiences Arg1:T38 Arg2:T43	
R34	Experiences Arg1:T44 Arg2:T43	
R29	Experiences Arg1:T46 Arg2:T16	
T64	Observation 906 920;926 934	función tímica afectada
R36	Location_of Arg1:T17 Arg2:T64	
R37	Experiences Arg1:T46 Arg2:T45	
R38	Experiences Arg1:T46 Arg2:T64	
R39	Overlap Arg1:T16 Arg2:T64	
R40	Overlap Arg1:T16 Arg2:T45	
R41	Causes Arg1:T48 Arg2:T19	
T65	Result_or_Value 953 961	positiva
#54	AnnotatorNotes T65	C1446409; Positive; Finding
R42	Has_Result_or_Value Arg1:T18 Arg2:T65	
R43	Causes Arg1:T47 Arg2:T65	
R44	Experiences Arg1:T49 Arg2:T20	
R45	Causes Arg1:T21 Arg2:T20	
R46	Experiences Arg1:T50 Arg2:T22	
T66	Observation 1122 1173	hayan participado en otros estudios de intervención
A14	Status T66 History_of
R48	Overlap Arg1:T66 Arg2:T52	
R49	Overlap Arg1:T23 Arg2:T52	
R50	Experiences Arg1:T53 Arg2:T24	
R51	Causes Arg1:T25 Arg2:T24	
R52	Causes Arg1:T35 Arg2:T24	
R53	Experiences Arg1:T54 Arg2:T26	
R54	Experiences Arg1:T55 Arg2:T28	
R55	Experiences Arg1:T55 Arg2:T29	
R56	Experiences Arg1:T55 Arg2:T30	
R57	Experiences Arg1:T55 Arg2:T31	
T67	Quantifier_or_Qualifier 1401 1406	grave
#56	AnnotatorNotes T67	C1547227; Severe - Severity of Illness Code; Intellectual Product
R58	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T67	
A15	Status T67 History_of
#57	AnnotatorNotes T18	C0201386; Measurement of Human immunodeficiency virus 1 antibody; Laboratory Procedure
R59	Experiences Arg1:T40 Arg2:T13	
R26	Location_of Arg1:T17 Arg2:T45	
A16	Experiencer T37 Patient
A17	Experiencer T39 Patient
A18	Experiencer T40 Patient
A19	Experiencer T42 Patient
A20	Experiencer T44 Family_member
A21	Experiencer T38 Other
A22	Experiencer T46 Patient
A23	Experiencer T49 Patient
A24	Experiencer T50 Patient
A25	Experiencer T51 Patient
A26	Experiencer T53 Patient
A27	Experiencer T54 Patient
A28	Experiencer T55 Patient
